Pharmanutra SpA
MIL:PHN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmanutra SpA
MIL:PHN
|
IT |
|
D
|
DS Sigma Holdings Bhd
KLSE:DSS
|
MY |
|
P
|
PCC Exol SA
WSE:PCX
|
PL |
|
Softronic AB
STO:SOF B
|
SE |
|
Intred SpA
F:M7P
|
IT |
|
Lucid Group Inc
F:CH2
|
US |
|
Native Mineral Resources Holdings Ltd
ASX:NMR
|
AU |
|
T
|
Teka Construction PCL
SET:TEKA
|
TH |
|
G
|
Garuda Metalindo Tbk PT
IDX:BOLT
|
ID |
|
Iodm Ltd
ASX:IOD
|
AU |
|
Uniflex Technology Inc
TWSE:3321
|
TW |
|
T
|
Toyoda Gosei Co Ltd
F:11T
|
JP |
|
Arypsa Inc
OTC:APYI
|
US |
Intrinsic Value
Is PHN undervalued or overvalued?
See the intrinsic value estimate for Pharmanutra SpA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PHN looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with PHN’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Pharmanutra SpA Does
Pharmanutra SpA develops and sells nutraceutical and medical food products, with a strong focus on iron-based supplements and other nutrition items used to support specific health needs. Its products are sold through pharmacies, doctors, and other healthcare channels, and some are used in clinical settings where patients need targeted nutritional support.
- Headquarters
- Italy IT
- Employees
- 128
- IPO date
- Jul 18, 2017
Pharmanutra has a narrow economic moat
Pharmanutra SpA has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Pharmanutra SpA
Earnings Waterfall
Pharmanutra SpA
The intrinsic value for Pharmanutra SpA (PHN) under the Base Case is hidden EUR.
Compared with the current market price of 71.1 EUR, the stock appears hidden.